Multi-omics derivation of a core gene signature for predicting therapeutic response and characterizing immune dysregulation in inflammatory bowel disease.

Front Immunol · 2025 · PMC12350116 · PMID 40821793

Europe PMC DOI

hedged sentence

0.2920

closest p · 5.8× alpha

0.2920

boldest claim

The sentences

did not reach statistical significancep = 0.292not close (p > 0.1)

While CHAD showed a similar trend toward better prognosis with high expression (HR = 0.77), this association did not reach statistical significance (p = 0.292) ( Figures 8K-N ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.